This document outlines a randomized controlled multinational, multicenter trial protocol to assess the effectiveness and safety of a 5-week Mokhuri treatment program compared with conventional nonsurgical treatments for symptomatic lumbar spondylolisthesis. The study involves a multinational, multicenter clinical trial with participants from the Mayo Clinic in the United States and the Mokhuri Oriental Medicine Hospital in Korea. The trial will evaluate clinical outcomes such as pain scores, disability indices, and walking tests over a follow-up period of up to 102 weeks. The study aims to provide clinical evidence on nonsurgical integrative interventions for patients with symptomatic lumbar spondylolisthesis.
documents/EFTA00305864.pdf
{}